Detalhe da pesquisa
1.
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
Oncologist
; 21(3): 279-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911408
2.
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.
Clin Breast Cancer
; 11(5): 297-305, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21729666